Medicare Enrolled
Dr. Lama Hashish, MD
Rheumatology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hashish from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hashish?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hashish
Dr. Lama Hashish is a rheumatology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hashish performed 171,187 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hashish received a total of $12,587 from 45 pharmaceutical and/or device companies across 701 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hashish is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 6% volume in TX
$12,587 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗171,187
Medicare services
Top 6% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
131,200 | $4 | $12 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
30,925 | $31 | $63 |
| Denosumab injection (Prolia/Xgeva) | 3,300 | $19 | $32 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
1,181 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
814 | $87 | $199 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
768 | $54 | $138 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
697 | $9 | $44 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
505 | $92 | $277 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
373 | $8 | $20 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
366 | $2 | $5 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
246 | $89 | $189 |
| Injection, methylprednisolone acetate, 40 mg | 159 | $6 | $15 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
150 | $100 | $400 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
140 | $6 | $15 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
76 | $4 | $10 |
| Methotrexate sodium, 50 mg | 68 | $2 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $65 | $134 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $107 | $308 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
42 | $45 | $135 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
29 | $34 | $101 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
23 | $11 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
18.6% high complexity
80.8% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,587
Total received (2018-2024)
Avg $1,798/year across 7 years
Top 27% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
701
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,692
2023
$1,808
2022
$1,469
2021
$1,511
2020
$1,407
2019
$2,440
2018
$2,260
Payments by company (2024)
ABBVIE INC.
$403
Amgen Inc.
$291
UCB, Inc.
$233
E.R. Squibb & Sons, L.L.C.
$183
GlaxoSmithKline, LLC.
$142
Mallinckrodt Hospital Products Inc.
$110
Celgene Corporation
$104
ANI Pharmaceuticals, Inc.
$75
Fresenius Kabi USA, LLC
$68
Aurinia Pharma U.S., Inc.
$28
Janssen Biotech, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Sandoz Inc.
$15
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,985
UCB, Inc.
$1,494
Horizon Therapeutics plc
$1,032
ABBVIE INC.
$976
GlaxoSmithKline, LLC.
$800
E.R. Squibb & Sons, L.L.C.
$791
AbbVie, Inc.
$685
PFIZER INC.
$475
Novartis Pharmaceuticals Corporation
$417
Lilly USA, LLC
$377
AbbVie Inc.
$357
Janssen Biotech, Inc.
$315
Boehringer Ingelheim Pharmaceuticals, Inc.
$284
Mallinckrodt Hospital Products Inc.
$267
Radius Health, Inc.
$225
Horizon Pharma plc
$199
Mallinckrodt LLC
$170
Bioventus LLC
$159
Mallinckrodt Enterprises LLC
$156
GENZYME CORPORATION
$135
DePuy Synthes Sales Inc.
$133
Janssen Scientific Affairs, LLC
$125
Fresenius Kabi USA, LLC
$107
Celgene Corporation
$104
Genentech USA, Inc.
$99
ANI Pharmaceuticals, Inc.
$95
Sandoz Inc.
$66
Alexion Pharmaceuticals, Inc.
$58
Antares Pharma, Inc.
$56
Celltrion USA Inc.
$54
Octapharma USA, Inc.
$50
Boston Scientific Corporation
$42
Organon LLC
$38
Ultragenyx Pharmaceutical Inc.
$31
Cumberland Pharmaceuticals, Inc.
$30
AstraZeneca Pharmaceuticals LP
$29
Aurinia Pharma U.S., Inc.
$28
Zyla Life Sciences, Inc.
$24
Medtronic, Inc.
$22
TerSera Therapeutics LLC
$19
SANOFI-AVENTIS U.S. LLC
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
MEDEXUS PHARMA, INC.
$15
Merck Sharp & Dohme Corporation
$14
Fidia Pharma USA Inc.
$14
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Adempas · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · FORTEO · GELSYN 3 · GELSYN-3 · HADLIMA · HUMIRA · HYM/HYN · HYRIMOZ · Humira · IDACIO · INFLECTRA · INTELLIS ADAPTIVESTIM · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Quzyttir · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPECTRA WAVEWRITER · SPRIX · STELARA · Supartz · TALTZ · TEPEZZA · TREMFYA · Tavneos · Tymlos · XELJANZ · YUFLYMA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
50
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hashish is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hashish experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hashish performed 131,200 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hashish receive payments from pharmaceutical companies?
Yes. Dr. Hashish received a total of $12,587 from 45 companies across 701 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hashish's costs compare to other rheumatologists in San Antonio?
Dr. Hashish's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hashish) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in San Antonio
Browse rheumatologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology